What is the current probability for "Will the FDA approve gedatolisib for advanced breast cancer?"?

Current Kalshi odds for "Will the FDA approve gedatolisib for advanced breast cancer?": Before Jan 1, 2027 85%, Before Jul 1, 2027 85%, Before Oct 1, 2026 61% (top 3 of 5 outcomes), refreshed continuously.

When does this market resolve?

This event resolves on 7/8/2027.

How is the probability calculated?

pdata reads the latest market prices directly from kalshi's public API and normalizes them to a 0-100 probability scale. See https://pdata.world/methodology for details on per-platform conventions.

Where can I get this data programmatically?

The JSON endpoint is https://api.pdata.world/api/v1/events/kalshi/KXFDAAPPROVE-GED. An MCP server with 9 tools is available at https://api.pdata.world/mcp. Full agent guide: https://pdata.world/agents.md.

opentrade on Kalshi

↗

event5 outcomes

Will the FDA approve gedatolisib for advanced breast cancer?

·Science and Technology·ends Jul 8, 2027

vol cum

$5.9k

vol 24h

$307

outcomes

ends

Jul 8, 2027

outcomesclick to inspect →

marketselected outcome

Before Jan 1, 2027

rank #1

United States

85¢

· 0.0pp

24h change

vol cum

$68

vol 24h

spread

0.05

ends

Jan 8, 2027

If the FDA approves gedatolisib for HR+/HER2-, PIK3CA wild-type advanced breast cancer for marketing before Jan 1, 2027, then the market resolves to Yes.

timeline

opened · May 14, 2026opencloses · Jan 8, 2027

prices over time · Before Jan 1, 2027 highlighted

−24h

now

volume · by outcomehover a column to inspect

no volume history